Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?
Author(s) -
Paul M. Ridker
Publication year - 2007
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2007.097907
Subject(s) - triglyceride , medicine , test (biology) , triglycerides blood , endocrinology , cholesterol , biology , paleontology
Historically, triglycerides have been measured in the fasting state for 2 reasons. First, because of the marked increaseintriglyceridesafterfatingestion,thevariabil- ity in triglyceride measurements is much smaller in the fasting state. Second, before the availability of direct assays for LDL cholesterol (LDL-C),1 estimation of LDL-Cwasperformedinclinicalpracticealmostexclu- sively by use of the Friedewald equation, which re- quires that both the HDL-C concentration and the fasting triglyceride concentration divided by 5 be sub- tracted from the total cholesterol concentration. The recommendations to measure triglycerides in the fasting state did not, however, derive from a con- sistent set of prospective cohort studies showing that fasting concentrations were superior to nonfasting concentrations for the detection of cardiovascular risk. Instead, following screening guidelines, most epidemi- ologic investigations simply relied on fasting triglycer-
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom